IL87390A - Protein carrier bound hapten and/or immunogenic or immunostimulatory substances and preparation thereof - Google Patents

Protein carrier bound hapten and/or immunogenic or immunostimulatory substances and preparation thereof

Info

Publication number
IL87390A
IL87390A IL87390A IL8739088A IL87390A IL 87390 A IL87390 A IL 87390A IL 87390 A IL87390 A IL 87390A IL 8739088 A IL8739088 A IL 8739088A IL 87390 A IL87390 A IL 87390A
Authority
IL
Israel
Prior art keywords
immunogenic
protein carrier
preparation
protein
carrier bound
Prior art date
Application number
IL87390A
Other languages
English (en)
Other versions
IL87390A0 (en
Original Assignee
Sleytr Uwe B
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sleytr Uwe B filed Critical Sleytr Uwe B
Publication of IL87390A0 publication Critical patent/IL87390A0/xx
Publication of IL87390A publication Critical patent/IL87390A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6068—Other bacterial proteins, e.g. OMP

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL87390A 1987-08-21 1988-08-09 Protein carrier bound hapten and/or immunogenic or immunostimulatory substances and preparation thereof IL87390A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873727987 DE3727987A1 (de) 1987-08-21 1987-08-21 Pharmazeutische struktur

Publications (2)

Publication Number Publication Date
IL87390A0 IL87390A0 (en) 1989-01-31
IL87390A true IL87390A (en) 1993-07-08

Family

ID=6334228

Family Applications (1)

Application Number Title Priority Date Filing Date
IL87390A IL87390A (en) 1987-08-21 1988-08-09 Protein carrier bound hapten and/or immunogenic or immunostimulatory substances and preparation thereof

Country Status (7)

Country Link
EP (1) EP0306473B1 (es)
JP (1) JP2708487B2 (es)
AT (1) ATE97323T1 (es)
AU (1) AU627154B2 (es)
DE (2) DE3727987A1 (es)
ES (1) ES2061734T3 (es)
IL (1) IL87390A (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7249491A (en) * 1990-03-02 1991-09-18 Alberta Research Council Inc. Improved immunogenic compositions
DE4115038A1 (de) * 1991-05-08 1992-11-12 Genentech Inc Neue konjugate, bestehend aus einem glykoprotein und einer nukleinsaeure-bindenden substanz
AU2005316041B2 (en) * 2004-12-14 2010-06-24 Alk Abello A/S Pharmaceutical composition comprising a bacterial cell displaying a heterologous proteinaceous compound
ES2383857B1 (es) * 2010-11-23 2013-05-13 Consejo Superior De Investigaciones Científicas (Csic) Haptenos e inmunoreactivos y su uso en la obtención de anticuerpos de familia e inmunoensayos para quinolonas

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR6789910D0 (pt) * 1966-10-17 1973-05-17 Fmc Corp Processo para preparar comestiveis contendo colagenio microcristalino
US4166767A (en) * 1976-03-25 1979-09-04 Dainippon Pharmaceutical Co., Ltd. Insolubilized antibody
DE2636206C3 (de) * 1976-08-12 1981-06-04 C.H. Boehringer Sohn, 6507 Ingelheim Trägerfixierte Enzyme sowie ihre Herstellung und Anwendung
JPS5428813A (en) * 1977-08-09 1979-03-03 Yuuichi Yamamura Solid preparation containing cell membrane extract substance used as suspension when using same
US4411832A (en) * 1979-11-26 1983-10-25 Pedro Cuatrecasas Polysaccharide matrices comprising macromolecular spacer arms for use as adsorbents in affinity chromatography techniques
DE3167679D1 (en) * 1980-03-31 1985-01-24 Inst Int Pathologie Cellulaire Pharmaceutical forms, their preparation and compositions containing the same
US4465668A (en) * 1981-02-27 1984-08-14 Asahi Kasei Kogyo Kabushiki Kaisha Method for improving intestinal absorption of cephalosporin derivatives
DE3224788A1 (de) * 1981-07-17 1983-02-03 South African Inventions Development Corp., Scientia, Pretoria,Transvaal Traegergebundenes immunogenes material
AT373278B (de) * 1982-03-23 1984-01-10 Inst Po Mikrobiologia Verfahren zur immobilisierung von mikrobenzellen mit einer glucose-isomerase-aktivitaet
US4604376A (en) * 1982-04-21 1986-08-05 Research Corporation Enteric compounds and complexes
US4663160A (en) * 1983-03-14 1987-05-05 Miles Laboratories, Inc. Vaccines for gram-negative bacteria
US4486344A (en) * 1983-03-28 1984-12-04 Miles Laboratories, Inc. Urea-linked immunogens, antibodies, and preparative method
SE8405493D0 (sv) * 1984-11-01 1984-11-01 Bror Morein Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel
CA1267087A (en) * 1985-02-14 1990-03-27 Nicolaas Visser Synthetic immunogen

Also Published As

Publication number Publication date
AU2142588A (en) 1989-03-16
JPH01207245A (ja) 1989-08-21
DE3885680D1 (de) 1993-12-23
DE3727987A1 (de) 1989-03-02
ATE97323T1 (de) 1993-12-15
EP0306473B1 (de) 1993-11-18
ES2061734T3 (es) 1994-12-16
EP0306473A1 (de) 1989-03-08
JP2708487B2 (ja) 1998-02-04
IL87390A0 (en) 1989-01-31
AU627154B2 (en) 1992-08-20

Similar Documents

Publication Publication Date Title
GR3007910T3 (es)
FI891896L (fi) Menetelmä antasidivalmisteiden valmistamiseksi, joilla on pidennetty viipymisaika mahalaukussa
PT82834B (pt) Processo para a preparacao de composicoes farmaceuticas, com sulobilizacao de proteinas, usando conjugacao de polimeros
FI981807L (fi) Menetelmä terapeuttisesti käyttökelpoisten starburst-konjugaattien valmistamiseksi
ES542919A0 (es) Un procedimiento para la preparacion de conjugados estables y covalentemente copulados de polisacarido-proteina.
NO903273D0 (no) Fremgangsmaate og blanding for aa gi haar forbedrete tilstandsegenskaper.
NO902526L (no) Fremgangsmaate og anordning for bretting av papiresker.
AU2843889A (en) Antigen antibody conjugate
PT81656B (pt) Processo para a preparacao de polissacarideos bacterianos neutros covalentemente modificados, e de conjugados covalentes estaveis desses polissacarideos e de proteinas imunogenicas
SE8804164A0 (sv) Farmaceutisk beredning
HU895847D0 (en) Antibody drug conjugate
BR1100939A (pt) Conjugado veìculo-droga e conjugado proteìna-droga
IL87390A (en) Protein carrier bound hapten and/or immunogenic or immunostimulatory substances and preparation thereof
CA2106563A1 (en) Cocaine derivatives and protein and polypeptide cocaine derivative conjugates and labels
ATE90790T1 (de) Verfahren zur herstellung einer festphasenmatrix.
AU8204887A (en) Conjugate vaccine
DE58901549D1 (de) Hapten-protein-konjugate und ihre verwendung.
CS269800B1 (en) Combined device for burners' ignition and checking
FR2640141B1 (fr) Conjugues macromoleculaires d'hemoglobine, leur procede de preparation et leurs applications
PT89689A (pt) Processo para a preparacao de polimeros electricamente condutores com solubilidade melhorada
EP0502100A4 (en) Reduced-protein subunit vaccine for swine dysentery
OA09419A (fr) Dérivés de l'acide 3-pyrrolidinylthio-1-azabicyclo (3.2.0.) -hept-2-ene-2-carboxylique et leur préparation.
Marshall Theoretical analysis of molecular polarization and interactions at electrode-solution interfaces.
Garnizov L’homme, XXV, I (93), janvier-mars, 1985
Marshall Responses to lactation

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees